Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001085146-08-000765
Filing Date
2008-05-22
Accepted
2008-05-22 17:02:13
Documents
6

Document Format Files

Seq Description Document Type Size
1 oracaccesspharma1_0508.htm SC 13D/A 79367
2 exhibit99_1.htm EX-99 10160
3 exhibit99_2.htm EX-99 4063
4 exhibit99_3.htm EX-99 68442
5 exhibit99_4.htm EX-99 168048
6 exhibit99_5.htm EX-99 301138
  Complete submission text file 0001085146-08-000765.txt   633503
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-33655 | Film No.: 08855353
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORACLE PARTNERS L P 200 GREENWICH AVENUE GREENWICH CT 06830
Business Address C/O ORACLE PARTNERS L P 712 FIFTH AVENUE 45TH FLOOR NEW YORK NY 10019 2038627900
FEINBERG LARRY N (Filed by) CIK: 0000926475 (see all company filings)

State of Incorp.: NY
Type: SC 13D/A